1. Home
  2. IX vs TEVA Comparison

IX vs TEVA Comparison

Compare IX & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orix Corp Ads

IX

Orix Corp Ads

HOLD

Current Price

$30.35

Market Cap

33.8B

Sector

Finance

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$31.41

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IX
TEVA
Founded
1950
1901
Country
Japan
Israel
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.8B
30.2B
IPO Year
1970
N/A

Fundamental Metrics

Financial Performance
Metric
IX
TEVA
Price
$30.35
$31.41
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$32.67
AVG Volume (30 Days)
133.0K
9.2M
Earning Date
02-09-2026
01-28-2026
Dividend Yield
2.47%
N/A
EPS Growth
11.37
N/A
EPS
2.62
0.62
Revenue
$20,512,909,787.00
$16,776,000,000.00
Revenue This Year
$9.03
$4.62
Revenue Next Year
$3.38
$0.34
P/E Ratio
$11.40
$51.46
Revenue Growth
6.22
0.02
52 Week Low
$17.75
$12.47
52 Week High
$30.82
$33.42

Technical Indicators

Market Signals
Indicator
IX
TEVA
Relative Strength Index (RSI) 62.83 56.69
Support Level $30.17 $31.92
Resistance Level $30.82 $32.86
Average True Range (ATR) 0.31 0.79
MACD -0.05 -0.26
Stochastic Oscillator 72.56 34.75

Price Performance

Historical Comparison
IX
TEVA

About IX Orix Corp Ads

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: